CPLX3 — Complexin-3
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CPLX3 — Complexin-3</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CPLX3</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Complexin-3</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>5q23.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[81571](https://www.ncbi.nlm.nih.gov/gene/81571)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[618251](https://www.omim.org/entry/618251)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000177468</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9BQY1](https://www.uniprot.org/uniprot/Q9BQY1)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>AD, epilepsy, intellectual disability, retinal degeneration</td>
</tr>
</table>
CPLX3 (Complexin-3) is a neuronal soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor (SNARE)-interacting protein that plays critical roles in regulating synaptic vesicle fusion, neurotransmitter release, and synaptic plasticity. As a member of the complexin family (CPLX1-4), CPLX3 has specialized functions in sensory synapses, particularly in the retina and olfactory system, as well as in specific populations of [neurons](/entities/neurons) in the brain. CPLX3 is essential for proper synaptic transmission at ribbon synapses of photoreceptor cells and bipolar cells, and regulates both excitatory and inhibitory synaptic transmission in central nervous system neurons [1][2].
--- [@buhl2013]
title: CPLX3 — Complexin-3 [@rizo2018]
--- [@shalaby2020]
.infobox.infobox-gene [@tan2019]
Overview
Mermaid diagram (expand to render)
Complexin-3 is a neuronal protein that regulates synaptic vesicle fusion by binding to the SNARE complex. It plays a critical role in regulating neurotransmitter release at ribbon synapses and conventional synapses in the retina and brain. CPLX3 is highly expressed in photoreceptor cells, bipolar cells, and various brain regions including the hippocampus and [cortex](/brain-regions/cortex). Mutations or dysregulation of CPLX3 have been implicated in retinal degeneration, epilepsy, and neurodevelopmental disorders.
Protein Structure
The CPLX3 protein (approximately 156 amino acids) contains several key structural features:
N-Terminal Domain
The N-terminal region contains the central α-helical domain that binds to assembled SNARE complexes. This domain:
- Binds to the ternary SNARE complex (syntaxin-1, SNAP-25, VAMP2)
- Stabilizes the pre-fusion SNARE complex
- Regulates the transition from priming to release-ready states
Central Region
The central linker region contains:
- Accessory α-helical domain (AHA)
- Membrane-binding region
- Phosphorylation sites for regulatory control
C-Terminal Domain
The C-terminus contains:
- Hydrophobic membrane-anchoring segment
- Palmitoylation site for synaptic membrane association
- Protein-protein interaction motifs
Molecular Function
SNARE Complex Regulation
CPLX3 regulates neurotransmitter release through direct interaction with the SNARE complex:
Priming Function
- CPLX3 stabilizes the assembled SNARE complex in a partially zippered state
- Prevents full SNARE complex assembly before calcium influx
- Maintains vesicles in a release-ready (primed) state
Release Triggering
- Upon calcium entry through voltage-gated calcium channels:
- CPLX3 undergoes conformational change
- Allows complete SNARE complex zippering
- Triggers synaptic vesicle fusion and neurotransmitter release
Dual Function Model
- Complexins act as both clamps (preventing premature fusion) and activators (facilitating triggered release)
- This dual role is crucial for precise temporal control of synaptic transmission [3]
Specific Roles in Sensory Synapses
In the retina, CPLX3 has unique functions:
- Regulates vesicle release at ribbon synapses (continuous synaptic transmission)
- Controls synaptic vesicle pools in photoreceptor terminals
- Modulates bipolar cell ribbon synapse function
- Essential for proper visual signal transduction
Expression Pattern
CPLX3 exhibits a distinctive expression pattern:
Retina
- Photoreceptor cells: High expression in rod and cone photoreceptors
- Bipolar cells: Strong expression in both ON and OFF bipolar cells
- Horizontal cells: Moderate expression
- Amacrine cells: Variable expression
Brain
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal neurons, dentate gyrus granule cells
- Cerebral cortex: Layer 2/3 pyramidal neurons, interneurons
- Olfactory bulb: Mitral cells, tufted cells
- Cerebellum: Purkinje cells, granule cells
- Substantia nigra: Dopaminergic neurons
Cellular Localization
- Synaptic vesicles in pre-synaptic terminals
- Pre-synaptic plasma membrane
- Ribbons in retinal photoreceptors
Disease Associations
Retinal Degeneration
CPLX3 mutations are associated with:
- Cone-rod dystrophy
- Progressive retinal degeneration
- Visual acuity loss
- Photoreceptor dysfunction [4]
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease):
- CPLX3 expression is altered in AD brains
- SNARE complex dysfunction contributes to synaptic loss
- Impaired neurotransmitter release affects learning and memory
- CPLX3 may interact with [amyloid-beta](/proteins/amyloid-beta) pathology [5]
Epilepsy
CPLX3 dysregulation is implicated in epilepsy:
- Altered inhibitory/excitatory balance at synapses
- Mutations cause seizure phenotypes in animal models
- Dysregulated synaptic transmission contributes to epileptogenesis
Neurodevelopmental Disorders
CPLX3 is linked to:
- Intellectual disability
- Autism spectrum disorders
- Developmental delay
- Synaptic developmental defects [6]
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
- SNARE-mediated vesicle trafficking is impaired
- Dopaminergic neuron synaptic dysfunction
- Interaction with [α-synuclein](/proteins/alpha-synuclein) pathology
Therapeutic Implications
Drug Development
Targeting CPLX3 and SNARE regulation:
- SNARE complex stabilizers: Enhance synaptic transmission
- Calcium channel modulators: Control release timing
- Synaptic vesicle cycle enhancers: Improve neurotransmitter release
Gene Therapy
For CPLX3-related retinal disorders:
- Viral vector delivery of functional CPLX3
- CRISPR-based gene editing
- Optogenetic approaches to restore vision
Biomarkers
CPLX3 expression may serve as:
- Indicator of synaptic integrity
- Marker for retinal health
- Therapeutic response indicator
Research Directions
Ongoing research focuses on:
- Understanding CPLX3 function at ribbon synapses
- Characterizing CPLX3 mutations in retinal disease
- Developing therapies for CPLX3-related disorders
- Elucidating CPLX3 roles in neurodegenerative diseases
- Single-cell analysis of CPLX3 in specific neuron populations
Background
The study of Cplx3 — Complexin 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Synaptic Dysfunction Pathway](/mechanisms/synaptic-dysfunction)
- [SNARE Complex](/proteins/snare-complex)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Epilepsy](/diseases/epilepsy)
- [Retina](/cell-types/retinal-photoreceptor-inner-segments)
- [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
Pathway Diagram
The following diagram shows the key molecular relationships involving CPLX3 — Complexin-3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)